Healthtech Startups
16,988 companies tagged Healthtech, with their investors and founders.
Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs. Its tests analyze each patient's tumor biology to help clinicians make personalized treatment decisions.
2 investors
Veradigm provides solutions for healthcare stakeholders including payers, providers, and life science companies, leveraging its provider network to deliver data insights and research acceleration capabilities. The company operates within the healthcare ecosystem to improve patient access and enable clinical research.
2 investors
St. Louis medical device maker of the SPiN electromagnetic thoracic navigation platform for lung cancer diagnosis; acquired by Olympus in 2020.
2 investors
Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
2 investors
Vergent develops tumor-targeted fluorescent imaging agents designed to enhance surgeons' ability to visualize tumors during minimally invasive and robotic-assisted cancer surgery. The company's lead program, abenacianine for injection, is in Phase 2b clinical evaluation for lung cancer surgery applications.
2 investors
Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally. The company's proprietary technology creates biological solutions for conditions such as chronic venous insufficiency, peripheral arterial disease, and heart valve disease.
2 investors
Verily is a health technology company that develops products and solutions for consumers and healthcare. It operates in the digital health and healthtech sector.
2 investors
VerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity. The company targets cancer patients across a broad range of cancer types.
2 investors
Verinnogen develops data collection technology for pre-clinical cancer research, aiming to improve the accuracy, repeatability, and reliability of research data. The company draws on expertise in cancer biology and medical device development.
2 investors
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
2 investors
Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement. The company operates in the medical device sector.
2 investors
Verse Therapy provides a practice management platform that helps independent speech-language pathologists handle administrative work, insurance processing, scheduling, and documentation while connecting them with clients through partnerships and marketing support. The service aims to reduce administrative burden on therapists so they can focus on patient care.
2 investors
Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
2 investors
2 investors
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease. The devices are intended for physicians treating patients with deep venous disease, positioning the company in the vascular medical device space.
2 investors
Vessi Medical develops a minimally invasive cryo spray system for treating urological conditions in the bladder, offering a non-surgical alternative to traditional procedures performed in hospital settings. The system enables office-based treatment without anesthesia in some cases, reducing complications and healthcare costs compared to conventional surgical approaches.
2 investors
Vessl designs adaptive prosthetic technology that adjusts to the body's dynamic changes to provide consistent comfort and natural movement for amputees. The company's Kinnβ’ system is engineered to function seamlessly in daily life without requiring constant adjustments.
2 investors
Vetmed Service MΓΌnchen is a veterinary medical service in Munich offering specialists in surgery/arthrosis, internal medicine, and ophthalmology. The website is currently under construction.
2 investors
VetPronto operates a veterinary service that brings licensed veterinarians to pets' homes and workplaces across multiple U.S. markets. The platform uses technology to manage medical records, client communication, and operational workflows, and offers telemedicine and integrated pharmacy services.
2 investors
Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.
2 investors
VetVerifi provides verified pet vaccination records along with smart tags and API access for pet care. Its services target pet owners and pet care providers such as boarding, housing, and veterinary businesses.
2 investors
Vheda Health offers turnkey, evidence-based chronic care, behavioral health, and maternal health programs delivered virtually to Medicaid, Medicare, and SNP health plans across the US. Its programs aim to increase member engagement, lower costs through reduced ER utilization and admissions, and improve health and quality outcomes.
2 investors
Vibrant Gastro develops a drug-free medical device using micro-vibrations to treat chronic idiopathic constipation in adults. The company's Vibrant System employs the Synchronized Activation Method to mechanically stimulate the colon and improve natural bowel motility.
2 investors
Vicarious Surgical develops a surgical robot for minimally invasive laparoscopic procedures, providing surgeons with 3D visualization and precise control. The system, which has received FDA Breakthrough Device Designation, targets hospitals, surgeons, and patients seeking advanced surgical care.
2 investors











